港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

高瓴概念

530.160

+2.2130.42%

漲家數：22

跌家數：26

平家數：7

市盈率：- -

高：542.443

開：527.909

低：516.727

收：527.947

資料載入中...

機構：歐洲央行可能已非常接近中性利率

和黃醫藥(00013.HK)HMPL-453治療肝內膽管癌II期臨牀試驗已完成患者入組

阿斯达克财经

百濟神州授出合共3.26萬股受限制股份單位

百濟神州(06160)授出購股權及受限制股份單位

百濟神州(06160.HK)授出合共3.26萬股受限制股份單位

中紅醫療：子公司獲得醫療器械註冊證

心通醫療-B預期2024年淨虧損同比收窄約87%至94%

格隆汇资讯

機構：歐洲央行如期降息避免引發市場動盪，未來不確定性仍存

暴降70%！泰格醫藥閃崩，CRO失去最後避風港

心通醫療-B(02160)發盈警預期2024年淨虧損約3000萬-6000萬元同比減少約87%至94%

智通财经网

京東健康2024年業績超預期總收入達到582億元

高瓴大幅減持百濟神州：或套現50億仍是重要股東

富達國際減持海吉亞醫療(06078)113.48萬股每股作價約16.83港元

石藥集團：I類新藥雙功能融合蛋白藥物JMT108獲臨牀試驗批准

百濟神州股東減持3224萬股，持股比例降至6.66%

Bitwise在歐洲推出同時追蹤比特幣和黃金的ETP

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":530.16,"timestamp":1741334919603,"preClose":527.9473,"halted":0,"volume":980509667,"delay":0,"changeRate":0.004191,"change":2.212646,"pbRate":2.561308,"amount":26591271419.5,"amplitude":0.048709,"prevYearClose":446.93042,"fiveDayClose":492.906,"twentyDayClose":463.639,"turnoverRate":0.00672,"marketCap":2931729303680,"floatMarketCap":2341637933184,"peRate":34.961436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":542.4425,"amplitude":0.048709,"preClose":527.9473,"low":516.72687,"pbRate":"2.561308","latestPrice":530.16,"volume":980509667,"delay":0,"open":527.90906,"prevYearClose":446.93042,"prevWeekClose":530.16,"prevMonthClose":492.906,"prevQuarterClose":446.93,"fiveDayClose":492.906,"twentyDayClose":463.639,"sixtyDayClose":464.552,"secType":"PLATE","market":"HK","turnoverRate":0.00672,"peRate":34.961436,"marketCap":2931729303680,"floatMarketCap":2341637933184,"timestamp":1741334919603,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":22,"down":26,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:16,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517169988","title":"機構：歐洲央行可能已非常接近中性利率","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169988","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169988?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 23:10","pubTimestamp":1741273822,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["BK1229","ZFmain","BK1258","ZTmain","ZBmain","BK1542","TNmain","BK1583","UBmain","09983","ZNmain"],"gpt_icon":0},{"id":"2517169457","title":"和黃醫藥(00013.HK)HMPL-453治療肝內膽管癌II期臨牀試驗已完成患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169457","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169457?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 23:05","pubTimestamp":1741273500,"startTime":"0","endTime":"0","summary":"和黄医药(00013.HK) 公布，HMPL-453(fanregratinib)用于治疗伴有成纤维细胞生长因子受体2融合/重排的肝内胆管癌患者的II期临床试验已完成患者入组。预计2025年年底左右公布研究的顶线结果。该研究旨在评估HMPL-453用于治疗伴有FGFR2融合/重排的晚期肝内胆管癌患者的疗效、安全性和药代动力学。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-06 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220520173825120_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220520173825120_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422784/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","BK1141","BK1587","03347","00013","BK1583","BK1588","BK1191"],"gpt_icon":0},{"id":"2517116937","title":"百濟神州授出合共3.26萬股受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2517116937","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517116937?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:37","pubTimestamp":1741271821,"startTime":"0","endTime":"0","summary":"格隆汇3月6日丨百济神州(06160.HK)公告，于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款向一名承授人授出可认购合共1,100股美国存托股份的购股权并向一百五十一名承授人授出涉及合共32,579股美国存托股份的受限制股份单位。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224232989eb6ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224232989eb6ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1500","06160","LU2328871848.SGD","LU0588546209.SGD","LU1969619763.USD","LU0307460666.USD","BK1588"],"gpt_icon":0},{"id":"2517853165","title":"百濟神州(06160)授出購股權及受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2517853165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517853165?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:15","pubTimestamp":1741270511,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款授予一名承授人可认购合共1100股美国存托股份的购股权。于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款授予151名承授人合共3.26万股美国存托股份受限制股份单位。该等受限制股份单位相当于42.35万股股份，约占本公告之日公司发行股份总数的0.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1500","688235","06160","ONC","BK1588","BK1583","LU2328871848.SGD","BK1161","BK4139","LU0307460666.USD","LU1969619763.USD","LU0588546209.SGD","BK0239"],"gpt_icon":0},{"id":"2517163194","title":"百濟神州(06160.HK)授出合共3.26萬股受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163194","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517163194?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:12","pubTimestamp":1741270358,"startTime":"0","endTime":"0","summary":"格隆汇3月6日丨百济神州(06160.HK)公告，于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款向一名承授人授出可认购合共1,100股美国存托股份的购股权并向一百五十一名承授人授出涉及合共32,579股美国存托股份的受限制股份单位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/06221248575249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK0239","LU0588546209.SGD","LU1969619763.USD","688235","BK1500","BK4139","06160","LU0307460666.USD","LU2328871848.SGD","BK1588","ONC","BK1583"],"gpt_icon":0},{"id":"2517165045","title":"中紅醫療：子公司獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165045","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517165045?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:08","pubTimestamp":1741270080,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月6日晚间，中红医疗发布公告称，公司子公司深圳迈德瑞纳生物科技有限公司（简称“迈德瑞纳”）于近期取得了广东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，迈德瑞纳申报的肠内营养泵医疗器械注册证已审批通过。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenttpc3265800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","09997","BK1583","159883","BK1222","BK0220","09996","300981"],"gpt_icon":0},{"id":"2517168156","title":"心通醫療-B預期2024年淨虧損同比收窄約87%至94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168156","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168156?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:58","pubTimestamp":1741269522,"startTime":"0","endTime":"0","summary":"格隆汇3月6日丨心通医疗-B公告，根据对集团截至2024年12月31日止年度未经审核管理账目的初步审阅及对董事会目前可得最新资料的评估，集团预期报告期录得净亏损约人民币3000万元至人民币6000万元，较截至2023年12月31日止年度减少约87%至94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306215850989eaca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306215850989eaca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02160","BK1583","BK1574"],"gpt_icon":0},{"id":"2517150447","title":"機構：歐洲央行如期降息避免引發市場動盪，未來不確定性仍存","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150447","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150447?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:58","pubTimestamp":1741269483,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d6184e4d27e8e91b8b00e52597fd1b8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["BK1542","BK1583","BK1229","09983","HK0000934320.USD","BK1258"],"gpt_icon":0},{"id":"2517168193","title":"暴降70%！泰格醫藥閃崩，CRO失去最後避風港","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168193","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168193?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:58","pubTimestamp":1741269480,"startTime":"0","endTime":"0","summary":"AI浪潮袭来，CRO行业正从“人力密集型”向“技术驱动型”演进。行业结构性调整的阵痛，无人能幸免。药明、康龙化成之后，轮到CRO血统最纯正的大哥——泰格医药了。作为中国CXO行业“最后的堡垒”，CRO一哥终于顶不住了——2024年迎来了业绩创纪录式的大跌：根据预告，其上市以来年营收首次出现下滑；归母净利润预计同比骤降72%-81%，这一力度也是上市后首次，盈利压力凸显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306221121989eafa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306221121989eafa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1141","BK1576","BK1583"],"gpt_icon":0},{"id":"2517150236","title":"心通醫療-B(02160)發盈警 預期2024年淨虧損約3000萬-6000萬元 同比減少約87%至94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150236","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150236?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:55","pubTimestamp":1741269335,"startTime":"0","endTime":"0","summary":"心通医疗-B(02160)公布，该集团预期2024年取得净亏损约人民币3000万-...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_37.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_37.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1100","02160","BK1583","BK1574"],"gpt_icon":0},{"id":"2517150788","title":"京東健康2024年業績超預期 總收入達到582億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150788","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150788?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:34","pubTimestamp":1741268092,"startTime":"0","endTime":"0","summary":"本报讯（记者袁传玺）3月6日，京东健康股份有限公司（以下简称“京东健康”）发布2024年全年业绩公告。2024年，京东健康总收入为582亿元，非国际财务报告准则指标下（Non-IFRS）净利润达47.9亿元，收入和净利润超过市场预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338762475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0456827905.SGD","BK1571","BK1591","BK1515","BK1142","LU0051755006.USD","BK1247","BK1583","86618","BK1589","06618"],"gpt_icon":0},{"id":"2517157675","title":"高瓴大幅減持百濟神州：或套現50億 仍是重要股東","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157675","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157675?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:29","pubTimestamp":1741267769,"startTime":"0","endTime":"0","summary":"由于百济神州这两日股价处于低点，若以今日股价计算，高瓴套现50亿港元。这是2024年12月以来，高瓴再次减持百济神州。百济神州此前公告称，高瓴于2023年6月8日至 2024年12月2日通过集中竞价和大宗交易方式合计减持21,997,317股。百济神州年营收272亿近期，百济神州发布业绩快报。不过，过去半年的时间，百济神州股价持续上涨，高瓴则持续减持，共套现至少超过70亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306212955963c3dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306212955963c3dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","BK1161","BK1500","LU1969619763.USD","06160","LU0307460666.USD","BK1583","BK1588","688235","LU0588546209.SGD"],"gpt_icon":0},{"id":"2517531159","title":"富達國際減持海吉亞醫療(06078)113.48萬股 每股作價約16.83港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517531159","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517531159?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 20:19","pubTimestamp":1741263559,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，2月27日，富达国际减持海吉亚医疗(06078)113.48万股，每股作价16.8258港元，总金额约为1909.39万港元。减持后最新持股数目为3674.96万股，最新持股比例为5.91%。本交易涉及其他关联方：Pandanus Associates Inc.和Pandanus Partners L.P.。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0502904849.HKD","LU0329678170.USD","BK4548","LU0455707207.USD","LU0329678337.USD","BK4503","BK4232","LU0737861772.HKD","BK1583","BK4022","LU0327786744.USD","LU2242644610.SGD","BK1209","LU0456842615.SGD","BK4539","LU0572944931.SGD","BK4526","06078","LU2488822045.USD","YMM"],"gpt_icon":0},{"id":"2517445159","title":"石藥集團：I類新藥雙功能融合蛋白藥物JMT108獲臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517445159","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517445159?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:58","pubTimestamp":1741262311,"startTime":"0","endTime":"0","summary":"近日，石药集团发布JMT108获中国临床试验批准的公告。该产品是一种重组全人源抗PD-1且融合IL-15的双功能融合蛋白，通过靶向PD-1阳性肿瘤浸润免疫细胞，解除PD-1和PD-L1相互作用导致的免疫抑制，并通过PD-1抗体结合依赖性地激活IL-15下游信号通路，进一步促进相关免疫细胞的增殖和活化，从而达到增强的抗肿瘤疗效。本次获批的临床适应症为晚期恶性肿瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306200013abeb4e69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306200013abeb4e69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287792.SGD","BK1521","IE0008368742.USD","IE00BZ08YR35.GBP","LU1152091754.HKD","IE00B031HY20.USD","LU1226288170.HKD","IE0008369823.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1226287529.USD","03347","01093","LU1008478684.HKD","LU1960683339.HKD","LU0326950275.SGD","LU1807302812.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","BK1191","BK1515","LU0072913022.USD","BK1583","LU1226288253.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU1226287875.USD","BK1141","LU0067412154.USD","LU0501845795.SGD","LU1951186391.HKD","BK1576","LU1993786604.SGD","LU0140636845.USD","LU0880133367.SGD"],"gpt_icon":0},{"id":"2517155469","title":"百濟神州股東減持3224萬股，持股比例降至6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517155469","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517155469?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:40","pubTimestamp":1741261203,"startTime":"0","endTime":"0","summary":"3月6日，百济神州发布公告，股东HHLR Fund,L.P.及其联属实体于2025年3月3日至3月4日通过大宗交易方式合计减持公司境外流通股股份3224万股。本次权益变动后，HHLR Fund,L.P.及其联属实体持有公司股份数量从1.25亿股减少至9281万股，所持股份占公司已发行股份总数的比例从8.97%减少至6.66%。此次减持不触及要约收购，且公司无控股股东、无实际控制人的状态未发生变化。2024年前三季度，百济神州实现收入191.36亿元，归母净利润-36.87亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306194014963c1ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306194014963c1ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","688235","BK1588","06160","BK1161","BK1583","LU0307460666.USD","BK1500","LU0588546209.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2517155427","title":"Bitwise在歐洲推出同時追蹤比特幣和黃金的ETP","url":"https://stock-news.laohu8.com/highlight/detail?id=2517155427","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517155427?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:38","pubTimestamp":1741261080,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/284425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["MGCmain","09439","09042","03439","SGUmain","XBTmain","GLD","83042","BK4585","159831","BK4594","BK1542","BTC","MSTU","BTC.USD.HKCC","NUGT","IBIT","159934","BK1229","BK1611","BK4601","GCmain","03008","BK1583","03042","IAU","09008","BK1258","GDX","SGCmain","DUST","518880","BTC.USD.CC","09983","BTCmain","BK4588"],"gpt_icon":0}],"pageSize":16,"totalPage":64,"pageCount":10,"totalSize":1015}]}}